Natco Pharma Limited has informed the Exchange about Link of Recording for the Concall held on 12th February, 2026
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has informed the stock exchanges that the audio recording of its Q3 FY25-26 earnings conference call, held on February 12, 2026 at 4:00 PM IST, has been uploaded to its website. The call covered the financial results for the quarter and nine months ended December 31, 2025. The filing has been made under Regulation 30 and 46 of SEBI's Listing Obligations and Disclosure Requirements, 2015. Investors can now listen to the full management discussion through the provided link.
This is a routine procedural disclosure and is unlikely to have any direct impact on the stock price. Investors who want deeper insights into Q3 performance and management outlook should listen to the audio recording for any forward-looking commentary.